Parexel and HealthVerity Announce Strategic Partnership to Address Complex Clinical Research Questions with Customized Real-World Data Solutions

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through to Commercialization, and HealthVerity, Inc., the trusted foundation for the rapid creation, exchange and management of healthcare and consumer data, today announced a strategic partnership to expand Parexel’s network of real-world data (RWD) sources to accelerate the delivery of drug development solutions for customers.

Read More
Announcing the Digital Health 150

Today we're coming at you live from Future of Health here in NYC. We have an amazing lineup of speakers and attendees, so look out for event highlights in our next newsletter.

Read More
Former FDA Commissioner Scott Gottlieb Joins Aetion’s Board of Directors

Today, Aetion, the health care technology company that delivers real-world evidence (RWE) for life sciences companies, payers, and regulatory agencies, announced that former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb has joined its board of directors. Gottlieb will advise the company as it expands the reach and utility of the Aetion Evidence Platform™, a scientifically validated tool to assess the safety, effectiveness, and value of treatments.

Read More